泰德医药(03880.HK)：中国证监会就公司H股全流通申请发出备案通知书

Core Viewpoint - The company, 泰德医药 (03880.HK), has received a filing notice from the China Securities Regulatory Commission (CSRC) regarding its conversion and listing, indicating that the filing process has been completed [1] Group 1 - The company received the filing notice on February 5, 2026, confirming the completion of the CSRC filing for conversion and listing [1] - If the company does not complete the share conversion within 12 months from the date of the filing notice, it must update the filing materials with the CSRC [1] - The details of the implementation plan for the conversion and listing have not yet been finalized as of the announcement date [1]